WALTHAM, Mass .– (COMMERCIAL THREAD) –Wolters Kluwer, Health announced today that it has expanded its portfolio of clinical natural language processing (cNLP) with Chart Review Accelerator. The new software intelligently analyzes patient medical records, extracting clinically important information such as conditions, medications, procedures, allergies, and lab results to effectively identify gaps in care. The solution is part of the Language of health platform and is designed specifically for clinical end users, accurately informing examinations of medical needs, HEDIS quality reporting and adjusting risks directly into their workflow.

Came from to look for To responses

Patient medical records range from one to hundreds to thousands of pages, depending on the patient. Manual review of these records, which are often very complex and out of order, is an expensive, costly and error-prone process. It also wastes valuable clinical resources which are better used to provide patient care. As research-based technology has become available, the incremental improvements offered to date still do not meet the real needs of clinicians.

“The traditional technologies deployed for chart review only search the records for relevant terms and produce a long list of results that clinicians must sift through to get the information they need,” said Frank jackson, vice-president and general manager of Health Language at Wolters Kluwer, Health. “In contrast, the Health Language Chart Review Accelerator has been specially designed to summarize research findings with a rich clinical context so that clinicians can focus on relevant information and more easily and quickly answer the specific questions they are trying to answer. to respond. ”

The new solution supports several important use cases, including:

  • Risk adjustment: Extracts clinical findings relevant to the most common HCCs for precise risk adjustment
  • Quality measurement report: Displays key information relevant to the most common HEDIS measurements from clinician notes to report more complete and accurate data
  • Examination of the medical file: Expedites review of patient charts for medical necessity and pre-authorization purposes
  • Predictive analytics: Enables the creation of structured and standardized data that powers predictive analytics, rule engines, and machine learning models

By combining cutting-edge data science with deep domain expertise, Wolters Kluwer’s cNLP Chart Review Accelerator delivers the information clinicians need to take action. Vendor-exclusive terminology from Wolters Kluwer, with over one million clinical synonyms, abbreviations and associated terms, is built into this cNLP solution to help clinicians optimize reporting and analysis, improve quality care and to maximize reimbursement, all without increasing their administrative burden.

Learn more about the Health Language Chart Review Accelerator.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for clinicians, nurses, accountants, lawyers and the tax, finance, audit, risk, compliance and regulation. We help our clients make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer achieved 2020 annual sales of 4.6 billion euros. The group serves customers in more than 180 countries, maintains operations in more than 40 countries and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides reliable clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision making and outcomes in healthcare. We support clinical efficacy, learning and research, clinical monitoring and compliance, and data solutions. For more information on our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information visit www.wolterskluwer.com, Follow us on Twitter, Facebook, LinkedIn, and Youtube.



Source link